基层医疗机构骨质疏松症诊断和治疗专家共识 (2021)

2021-07-25 中国健康促进基金会 中国骨质疏松杂志.2021.27(7):937-944.

基层医疗机构是诊治骨质疏松症的前沿阵地,为了解决基层医疗机构在骨质疏松症防治过程中面临的诊断、治疗和管理问题,中国健康促进基金会基层医疗机构骨质疏松症诊断与治疗专家共识委员会组织专家编写了《基层医疗机

中文标题:

基层医疗机构骨质疏松症诊断和治疗专家共识 (2021)

发布机构:

中国健康促进基金会

发布日期:

2021-07-25

简要介绍:

基层医疗机构是诊治骨质疏松症的前沿阵地,为了解决基层医疗机构在骨质疏松症防治过程中面临的诊断、治疗和管理问题,中国健康促进基金会基层医疗机构骨质疏松症诊断与治疗专家共识委员会组织专家编写了《基层医疗机构骨质疏松症诊断与治疗专家共识( 2021) 》,为基层医疗机构骨质疏松症的临床诊疗提供参考。该共识认为,骨质疏松症是一种以骨量低,骨组织微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病,可分为原发性和继发性两类。推荐基层医疗机构通过骨质疏松症高危因素和简易筛查工具进行初步筛查。骨质疏松症的诊断包括高危人群、临床诊断和鉴别诊断。骨质疏松症的治疗包括调整生活方式、基础治疗、中药内服外治、中西医结合、练功和骨折处理及疗效判定。基层骨质疏松症的管理可从人群筛查、数据建档,分级诊疗、双向转诊,规范治疗、定期随访着手。

相关资料下载:
[AttachmentFileName(sort=1, fileName=基层医疗机构骨质疏松症诊断和治疗专家共识_2021_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=652fd1c0021a1e19, title=基层医疗机构骨质疏松症诊断和治疗专家共识 (2021), enTitle=, guiderFrom=中国骨质疏松杂志.2021.27(7):937-944., authorId=0, author=, summary=基层医疗机构是诊治骨质疏松症的前沿阵地,为了解决基层医疗机构在骨质疏松症防治过程中面临的诊断、治疗和管理问题,中国健康促进基金会基层医疗机构骨质疏松症诊断与治疗专家共识委员会组织专家编写了《基层医疗机, cover=https://img.medsci.cn/2021731/1627738658443_2020535.jpg, journalId=0, articlesId=null, associationId=1223, associationName=中国健康促进基金会, associationIntro=中国健康促进基金会 , copyright=0, guiderPublishedTime=Sun Jul 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>基层医疗机构是诊治骨质疏松症的前沿阵地,为了解决基层医疗机构在骨质疏松症防治过程中面临的诊断、治疗和管理问题,中国健康促进基金会基层医疗机构骨质疏松症诊断与治疗专家共识委员会组织专家编写了《基层医疗机构骨质疏松症诊断与治疗专家共识( 2021) 》,为基层医疗机构骨质疏松症的临床诊疗提供参考。该共识认为,骨质疏松症是一种以骨量低,骨组织微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病,可分为原发性和继发性两类。推荐基层医疗机构通过骨质疏松症高危因素和简易筛查工具进行初步筛查。骨质疏松症的诊断包括高危人群、临床诊断和鉴别诊断。骨质疏松症的治疗包括调整生活方式、基础治疗、中药内服外治、中西医结合、练功和骨折处理及疗效判定。基层骨质疏松症的管理可从人群筛查、数据建档,分级诊疗、双向转诊,规范治疗、定期随访着手。</p> </div> </div> </div>, tagList=[TagDto(tagId=644, tagName=骨质疏松症)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=644, guiderKeyword=骨质疏松症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6356, appHits=308, showAppHits=0, pcHits=912, showPcHits=6044, likes=1, shares=45, comments=9, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-07-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 31 21:37:46 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 05:15:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=基层医疗机构骨质疏松症诊断和治疗专家共识_2021_.pdf)])
基层医疗机构骨质疏松症诊断和治疗专家共识_2021_.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214733, encodeId=a4d91214e3397, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:47:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186024, encodeId=c14c118602439, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a7f5313131, createdName=148905d8m16暂无昵称, createdTime=Wed Jan 19 14:53:37 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078387, encodeId=063910e8387d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70566386981, createdName=ms8000001368665579, createdTime=Thu Dec 09 10:42:59 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065616, encodeId=faa8106561675, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d05443443, createdName=ms8000002129192736, createdTime=Sun Oct 31 21:56:17 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011964, encodeId=5ba81011964b4, content=维生素D和钙片是基础,降钙素和磷酸盐类药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca85445755, createdName=唔该, createdTime=Fri Aug 27 10:13:33 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214733, encodeId=a4d91214e3397, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:47:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186024, encodeId=c14c118602439, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a7f5313131, createdName=148905d8m16暂无昵称, createdTime=Wed Jan 19 14:53:37 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078387, encodeId=063910e8387d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70566386981, createdName=ms8000001368665579, createdTime=Thu Dec 09 10:42:59 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065616, encodeId=faa8106561675, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d05443443, createdName=ms8000002129192736, createdTime=Sun Oct 31 21:56:17 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011964, encodeId=5ba81011964b4, content=维生素D和钙片是基础,降钙素和磷酸盐类药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca85445755, createdName=唔该, createdTime=Fri Aug 27 10:13:33 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2022-01-19 148905d8m16暂无昵称

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214733, encodeId=a4d91214e3397, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:47:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186024, encodeId=c14c118602439, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a7f5313131, createdName=148905d8m16暂无昵称, createdTime=Wed Jan 19 14:53:37 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078387, encodeId=063910e8387d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70566386981, createdName=ms8000001368665579, createdTime=Thu Dec 09 10:42:59 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065616, encodeId=faa8106561675, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d05443443, createdName=ms8000002129192736, createdTime=Sun Oct 31 21:56:17 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011964, encodeId=5ba81011964b4, content=维生素D和钙片是基础,降钙素和磷酸盐类药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca85445755, createdName=唔该, createdTime=Fri Aug 27 10:13:33 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-12-09 ms8000001368665579

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214733, encodeId=a4d91214e3397, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:47:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186024, encodeId=c14c118602439, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a7f5313131, createdName=148905d8m16暂无昵称, createdTime=Wed Jan 19 14:53:37 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078387, encodeId=063910e8387d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70566386981, createdName=ms8000001368665579, createdTime=Thu Dec 09 10:42:59 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065616, encodeId=faa8106561675, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d05443443, createdName=ms8000002129192736, createdTime=Sun Oct 31 21:56:17 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011964, encodeId=5ba81011964b4, content=维生素D和钙片是基础,降钙素和磷酸盐类药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca85445755, createdName=唔该, createdTime=Fri Aug 27 10:13:33 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-10-31 ms8000002129192736

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214733, encodeId=a4d91214e3397, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:47:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186024, encodeId=c14c118602439, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a7f5313131, createdName=148905d8m16暂无昵称, createdTime=Wed Jan 19 14:53:37 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078387, encodeId=063910e8387d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70566386981, createdName=ms8000001368665579, createdTime=Thu Dec 09 10:42:59 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065616, encodeId=faa8106561675, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d05443443, createdName=ms8000002129192736, createdTime=Sun Oct 31 21:56:17 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011964, encodeId=5ba81011964b4, content=维生素D和钙片是基础,降钙素和磷酸盐类药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca85445755, createdName=唔该, createdTime=Fri Aug 27 10:13:33 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-08-27 唔该

    维生素D和钙片是基础,降钙素和磷酸盐类药物治疗

    0

拓展阅读

2017 ACP临床实践指南:治疗低骨密度或骨质疏松症预防骨折

美国医学会(AMA,American Medical Association) · 2017-05-09

2017 SIOT临床指南:骨质疏松症的预防和治疗

意大利骨科和创伤外科学会(SIOT,Italian Society for Orthopaedics and Traumatology) · 2017-10-20

2018 法国绝经后骨质疏松症的管理建议(更新版)

法国风湿病学学会(SFR,French Society for Rheumatology) · 2018-04-11

2019 TES临床实践指南:女性绝经后骨质疏松症的药物治疗

美国内分泌学会(TES,The Endocrine Society) · 2019-03-25